Radium-223 in Combination With Enzalutamide
NCT02225704
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
45
Enrollment
NETWORK
Sponsor class
Conditions
Prostate Cancer
Interventions
DRUG:
Radium-223 and enzalutamide
Sponsor
Cancer Trials Ireland